3D Blood-Brain Barrier-Organoids as a Model for Lyme Neuroborreliosis
Source Adams et al., 2023 · Centre for Medical Parasitology, Department of Immunology and Microbiology, University of Copenhagen · 10.1016/j.isci
Abstract
This protocol describes the generation and use of 3D blood-brain barrier (BBB) organoids composed of human brain endothelial cells, pericytes, and astrocytes to model Lyme neuroborreliosis. The organoids are used to assess the ability of Borrelia burgdorferi genospecies to invade the BBB, induce structural changes, and disrupt tight junctions, providing a human-relevant in vitro model for studying spirochetal CNS infection.
Protocol overview
25 steps across 6 phases
- 1 Prepare agarose-coated wells
- 2 Prepare cell suspension for organoid seeding
- 3 Seed multicellular organoids
- 4 Allow organoid self-assembly
- 5 Verify cellular orientation by astrocyte staining
- 1 Culture Borrelia spirochetes
- 2 Stain spirochetes for flow cytometry
- 3 Wash and resuspend spirochetes
- 4 Final spirochete preparation for co-culture
- 5 Co-incubate Borrelia with BBB-organoids
- 1 Pool and fix organoids
- 2 Prepare organoids for imaging
- 3 Confocal microscopy imaging
- 4 Quantify spirochete invasion by volume
- 1 Calculate organoid volume
- 2 Calculate organoid roundness
- 3 Calculate organoid circularity
- 1 Fix organoids and permeabilize
- 2 Block non-specific binding and stain ZO-1
- 3 Apply secondary antibody
- 4 Stain nuclei and image
- 5 Quantify tight junction disruption
- 1 Prepare organoids and positive control
- 2 Apply Live/Dead stain
- 3 Image and quantify cell death
Full SOP
Create a free account to access this protocol
Join OrganMatch to unlock step-by-step procedures, reagent concentrations, QC checklists, and downloadable batch record templates.
Create free accountAlready registered? Log in
Attribution
This SOP was authored by Organthis based on the published method in Adams et al., 2023. The originating laboratory holds no rights in this SOP and has not endorsed it unless marked Verified.
This wording is awaiting legal review.
Something wrong with this entry? Report an issue with this protocol